olverembatinib
Commercial- Indications
- Chronic myeloid leukemia, Gastrointestinal stromal tumor, COVID-19
Company intelligence / Profile preview
Tanner Pharma Group
Charlotte, North Carolina, United Statestannerpharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Tanner Pharma Group specializes in enabling global access to medicines through managed access programs, international commercialization support, clinical trial supply sourcing/logistics, and licensing/acquisition services. It does not conduct its own drug development or clinical trials but partners with manufacturers to expand patient access worldwide.
- Therapeutic areas
- OtherRare Diseases
- Industry
- Consulting
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Beyond the preview
Go deeper on Tanner Pharma Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tanner Pharma Group.